Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...

BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (ADT) (the “Company” or “ADT”), today announced that its indirect wholly owned subsidiary, The ADT Security Corporation, has priced its ...

BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (ADT) (the “Company” or “ADT”), today announced that its indirect wholly owned subsidiary, The ADT Security Corporation, is proposing to ...

IRVING, Texas — Security integrator Everon, which provides commercial security, video, fire and life safety solutions, today announces it has entered into a definitive agreement to acquire the ...

ADT said it has agreed to sell assets used to operate its multifamily business to Everon for $55 million. The home-security company said Monday that the divestiture includes ADT's sales to businesses ...

I’ve been working with computers for ages, starting with a multi-year stint in purchasing for a major IBM reseller in New York City before eventually landing at PCMag (back when it was still in print ...

The FDA has begun accepting applications for a priority pathway designed to slash review times to between one and two months, giving developers of medicines that align with U.S. national health ...

FRASER, Mich. (WXYZ) — One year after taking over nearly 80 municipal contracts from GFL Environmental, Priority Waste says it has made significant investments to ...

The Priority Current Plus E-bike is the perfect all-around electric bike, perfect for beginners and seasoned commuters alike. At just 55 pounds, it's compatible with most hitch racks—perfect for use ...

Matthew Herper covers medical innovation — both its promise and its perils. On Tuesday, the Food and Drug Administration said that it would offer U.S. companies that support “U.S. national interests” ...

The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. The federal outfit’s ...